​

Accolade (ACCD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ACCD Stock Forecast

Accolade stock forecast is as follows: an average price target of $7.03 (represents a 2.18% upside from ACCD’s last price of $6.88) and a rating consensus of 'Hold', based on 17 wall street analysts offering a 1-year stock forecast.

ACCD Price Target

The average price target for Accolade (ACCD) is $7.03 based on 1-year price targets from 17 Wall Street analysts in the past 3 months, with a price target range of $7.03 to $7.03. This represents a potential 2.18% upside from ACCD's last price of $6.88.

ACCD Analyst Ratings

Hold

According to 17 Wall Street analysts, Accolade's rating consensus is 'Hold'. The analyst rating breakdown for ACCD stock is 0 'Strong Buy' (0.00%), 8 'Buy' (47.06%), 9 'Hold' (52.94%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Accolade Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 09, 2025David GrossmanStifel Nicolaus$7.03$6.862.48%2.18%
Jan 08, 2025Richard CloseCanaccord Genuity$7.03$6.862.48%2.18%
Jun 28, 2024David GrossmanStifel Nicolaus$8.00$3.58123.46%16.28%
Jun 28, 2024Richard CloseCanaccord Genuity$13.00$6.39103.44%88.95%
Jun 28, 2024Ryan MacDonaldNeedham$8.00$6.3925.20%16.28%
Jun 28, 2024Jailendra SinghTruist Financial$9.00$6.3940.85%30.81%
Jun 28, 2024Stephanie DavisBarclays$5.50$6.39-13.93%-20.06%
Jun 28, 2024Gil LuriaD.A. Davidson$5.00$6.39-21.75%-27.33%
Apr 30, 2024Stan BerenshteynWells Fargo$10.00$8.1922.10%45.35%
Oct 04, 2023Ricky GoldwasserMorgan Stanley$14.00$10.0339.58%103.49%
Jun 30, 2023Ryan MacDonaldNeedham$17.00$13.6124.91%147.09%
Jun 30, 2023Ryan MacDonaldNeedham$14.27$12.6412.90%107.41%
Jan 10, 2023Ryan MacDonaldNeedham$15.00$9.6056.25%118.02%
Jul 12, 2022Stan BerenshteynWells Fargo$8.00$9.87-18.95%16.28%
Jul 01, 2022Richard CloseCanaccord Genuity$12.00$9.5325.92%74.42%
Jul 01, 2022Ryan MacDonaldNeedham$12.00$9.5325.92%74.42%
May 02, 2022Glen SantangeloJefferies$13.00$6.43102.18%88.95%
Apr 29, 2022Piper Sandler$11.00$11.06-0.54%59.88%
Apr 29, 2022Credit Suisse$9.00$11.06-18.63%30.81%
Apr 29, 2022Jeffrey GarroPiper Sandler$11.00$5.5697.84%59.88%
Jan 11, 2022David LarsenBTIG$35.00$24.4443.21%408.72%
Jan 11, 2022Jeffrey GarroPiper Sandler$35.00$24.4443.21%408.72%
Jan 10, 2022Stephanie DavisLeerink Partners$52.00$19.14171.68%655.81%
Dec 01, 2021Glen SantangeloJefferies$33.00$24.3435.58%379.65%

The latest Accolade stock forecast, released on Jan 09, 2025 by David Grossman from Stifel Nicolaus, set a price target of $7.03, which represents a 2.48% increase from the stock price at the time of the forecast ($6.86), and a 2.18% increase from ACCD last price ($6.88).

Accolade Price Target by Period

1M3M12M
# Anlaysts229
Avg Price Target$7.03$7.03$8.06
Last Closing Price$6.88$6.88$6.88
Upside/Downside2.18%2.18%17.15%

In the current month, the average price target of Accolade stock is $7.03, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 2.18% increase as opposed to Accolade's last price of $6.88. This month's average price target is down 0.00% compared to last quarter, and down -12.78% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Jan 09, 2025Raymond JamesOutperformMarket PerformDowngrade
Jan 08, 2025NeedhamBuyHoldDowngrade
Jan 08, 2025William BlairMarket PerformDowngrade
Oct 09, 2024StephensBuyBuyHold
Oct 04, 2024Raymond JamesOutperformOutperformHold
Oct 04, 2024NeedhamBuyBuyHold
Oct 04, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Jun 28, 2024Canaccord GenuityBuyBuyHold
Jun 28, 2024NeedhamBuyBuyHold
Jun 28, 2024BarclaysEqual-WeightEqual-WeightHold
Apr 30, 2024Wells FargoEqual-WeightEqual-WeightHold
Feb 26, 2024Raymond JamesUnderperformUnderperformHold
Feb 26, 2024Wells FargoBuyBuyHold
Jan 19, 2024Wells FargoBuyBuyHold
Jan 09, 2024WedbushOutperformOutperformHold
Oct 05, 2023Raymond JamesOutperformOutperformHold
Oct 04, 2023NeedhamBuyBuyHold
Oct 04, 2023GuggenheimBuyBuyHold
Oct 04, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Jun 26, 2023NeedhamBuyBuyHold
May 24, 2023Exane BNP ParibasUnderperformDowngrade
May 24, 2023BarclaysOverweightUpgrade
May 24, 2023Raymond JamesOutperformMarket PerformInitialise
May 24, 2023Bank of America SecuritiesNeutralBuyUpgrade
Apr 21, 2023Wells FargoEqual-WeightEqual-WeightHold
Mar 23, 2023GuggenheimBuyUpgrade
Feb 02, 2023Raymond JamesOutperformInitialise
Jan 10, 2023NeedhamBuyBuyHold
Oct 04, 2022NeedhamBuyBuyHold
Oct 04, 2022Canaccord GenuityBuyBuyHold
Jul 14, 2022Bank of America SecuritiesNeutralNeutralHold
Jul 12, 2022Wells FargoEqual-WeightEqual-WeightHold
Jul 01, 2022NeedhamBuyBuyHold
Jul 01, 2022Goldman SachsBuyBuyHold
Jul 01, 2022Canaccord GenuityBuyBuyHold
May 02, 2022JefferiesBuyBuyHold
May 02, 2022Wells FargoUnderweightEqual-WeightUpgrade
May 02, 2022Wells FargoUnderweightUpgrade
Apr 29, 2022BTIGNeutralDowngrade
Apr 29, 2022Piper SandlerOverweightOverweightHold
Apr 29, 2022NeedhamBuyBuyHold
Apr 29, 2022SVB LeerinkMarket PerformDowngrade
Apr 29, 2022Morgan StanleyEqual-WeightDowngrade
Apr 29, 2022Credit SuisseNeutralDowngrade

Accolade's last stock rating was published by Raymond James on Jan 09, 2025. The company Downgrade its ACCD rating from "Outperform" to "Market Perform".

Accolade Financial Forecast

Accolade Revenue Forecast

Mar 27Nov 26Aug 26May 26Mar 26Nov 25Aug 25May 25Mar 25Nov 24Aug 24May 24Mar 24Nov 23Aug 23May 23Mar 23Dec 22Aug 22May 22Mar 22Dec 21Aug 21May 21Mar 21Dec 20Aug 20May 20
Revenue-------------$99.37M$96.86M$93.23M--$87.64M$85.53M--$73.29M$59.53M--$36.79M$35.89M
Avg Forecast$172.73M$136.67M$132.03M$132.73M$159.68M$121.17M$120.34M$121.51M$142.24M$105.99M$104.87M$105.95M$123.91M$96.16M$94.09M$90.82M$99.44M$100.94M$82.86M$81.98M$91.58M$75.89M$70.37M$55.67M$56.64M$36.25M$34.62M$34.14M
High Forecast$176.18M$139.39M$134.67M$135.38M$162.87M$123.59M$122.75M$123.94M$145.15M$106.79M$104.95M$106.32M$123.91M$96.64M$95.96M$92.64M$101.43M$121.12M$84.54M$83.64M$93.44M$77.43M$71.80M$56.80M$57.79M$36.99M$35.33M$34.83M
Low Forecast$166.68M$131.87M$127.40M$128.08M$154.08M$116.92M$116.12M$117.25M$136.87M$105.36M$104.78M$105.59M$123.91M$95.39M$90.79M$87.64M$95.96M$80.75M$80.91M$80.05M$89.42M$74.10M$68.71M$54.36M$55.30M$35.40M$33.81M$33.33M
# Analysts554843369949910998154475558555
Surprise %-------------1.03%1.03%1.03%--1.06%1.04%--1.04%1.07%--1.06%1.05%

Accolade's average Quarter revenue forecast for Mar 24 based on 9 analysts is $123.91M, with a low forecast of $123.91M, and a high forecast of $123.91M. ACCD's average Quarter revenue forecast represents a 24.69% increase compared to the company's last Quarter revenue of $99.37M (Nov 23).

Accolade EBITDA Forecast

Mar 27Nov 26Aug 26May 26Mar 26Nov 25Aug 25May 25Mar 25Nov 24Aug 24May 24Mar 24Nov 23Aug 23May 23Mar 23Dec 22Aug 22May 22Mar 22Dec 21Aug 21May 21Mar 21Dec 20Aug 20May 20
# Analysts554843369949910998154475558555
EBITDA-------------$-8.29M$-20.38M$-25.94M--$-34.47M$-34.81M--$-63.41M$-39.37M--$-10.96M$-10.71M
Avg Forecast$-49.25M$-38.97M$-37.64M$-37.84M$-45.53M$-34.55M$-34.31M$-34.64M$-40.55M$-30.22M$-29.90M$-30.21M$-14.20M$-27.42M$-26.83M$-25.89M$-12.91M$90.57M$-9.82M$-9.72M$-11.73M$-9.00M$-8.34M$-25.75M$-6.71M$-4.30M$-9.04M$-4.05M
High Forecast$-47.52M$-37.60M$-36.32M$-36.52M$-43.93M$-33.33M$-33.11M$-33.43M$-39.02M$-30.04M$-29.87M$-30.10M$-11.36M$-27.20M$-25.88M$-24.99M$-10.32M$108.69M$-9.59M$-9.49M$-9.39M$-8.78M$-8.15M$-20.60M$-6.56M$-4.20M$-7.23M$-3.95M
Low Forecast$-50.23M$-39.74M$-38.40M$-38.60M$-46.44M$-35.24M$-35.00M$-35.34M$-41.38M$-30.45M$-29.92M$-30.31M$-17.04M$-27.55M$-27.36M$-26.41M$-15.49M$72.46M$-10.02M$-9.91M$-14.08M$-9.18M$-8.51M$-30.90M$-6.85M$-4.38M$-10.85M$-4.13M
Surprise %-------------0.30%0.76%1.00%--3.51%3.58%--7.60%1.53%--1.21%2.65%

undefined analysts predict ACCD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Accolade's previous annual EBITDA (undefined) of $NaN.

Accolade Net Income Forecast

Mar 27Nov 26Aug 26May 26Mar 26Nov 25Aug 25May 25Mar 25Nov 24Aug 24May 24Mar 24Nov 23Aug 23May 23Mar 23Dec 22Aug 22May 22Mar 22Dec 21Aug 21May 21Mar 21Dec 20Aug 20May 20
# Analysts554843369949910998154475558555
Net Income-------------$-21.06M$-32.83M$-38.23M--$-46.52M$-342.82M--$-62.36M$-48.71M--$-15.37M$-13.96M
Avg Forecast$10.75M$-16.13M$-19.62M$-22.85M$8.33M$-20.97M$-23.12M$-25.40M$4.15M$-26.15M$-35.74M$-38.71M$-26.83M$-36.06M$-43.49M$-49.80M$-24.39M$53.89M$-57.56M$-59.10M$-22.17M$-62.30M$-47.15M$-31.86M$-7.34M$-26.69M$-12.68M$-29.43M
High Forecast$11.03M$-15.39M$-18.73M$-21.81M$8.55M$-20.01M$-22.06M$-24.25M$8.30M$-21.93M$-34.11M$-36.95M$-21.46M$-29.01M$-41.51M$-47.53M$-19.51M$64.67M$-55.80M$-57.29M$-17.74M$-60.39M$-45.71M$-25.49M$-7.12M$-25.87M$-10.14M$-28.53M
Low Forecast$10.26M$-16.55M$-20.13M$-23.44M$7.95M$-21.51M$-23.72M$-26.06M$-2.08M$-29.53M$-36.67M$-39.71M$-32.20M$-40.76M$-44.62M$-51.09M$-29.27M$43.11M$-59.08M$-60.66M$-26.61M$-63.94M$-48.40M$-38.23M$-7.53M$-27.40M$-15.22M$-30.20M
Surprise %-------------0.58%0.75%0.77%--0.81%5.80%--1.32%1.53%--1.21%0.47%

Accolade's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ACCD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Accolade SG&A Forecast

Mar 27Nov 26Aug 26May 26Mar 26Nov 25Aug 25May 25Mar 25Nov 24Aug 24May 24Mar 24Nov 23Aug 23May 23Mar 23Dec 22Aug 22May 22Mar 22Dec 21Aug 21May 21Mar 21Dec 20Aug 20May 20
# Analysts554843369949910998154475558555
SG&A-------------$41.70M$40.34M$41.11M--$45.96M$45.85M--$50.18M$46.97M--$14.33M$12.98M
Avg Forecast$79.29M$62.73M$60.60M$60.93M$73.30M$55.62M$55.24M$55.78M$65.29M$48.65M$48.14M$48.63M$41.23M$44.14M$43.19M$41.69M$37.48M$46.33M$37.87M$37.47M$34.07M$34.69M$32.16M$30.72M$25.89M$16.57M$11.83M$15.60M
High Forecast$80.87M$63.98M$61.81M$62.14M$74.76M$56.73M$56.34M$56.89M$66.63M$49.02M$48.17M$48.80M$49.47M$44.36M$44.05M$42.52M$44.98M$55.60M$38.64M$38.23M$40.89M$35.39M$32.82M$36.87M$26.41M$16.90M$14.19M$15.92M
Low Forecast$76.51M$60.53M$58.48M$58.79M$70.72M$53.67M$53.30M$53.82M$62.83M$48.36M$48.10M$48.46M$32.98M$43.79M$41.67M$40.23M$29.98M$37.06M$36.98M$36.59M$27.26M$33.87M$31.41M$24.58M$25.28M$16.18M$9.46M$15.24M
Surprise %-------------0.94%0.93%0.99%--1.21%1.22%--1.56%1.53%--1.21%0.83%

Accolade's average Quarter SG&A projection for Mar 24 is $41.23M, based on 9 Wall Street analysts, with a range of $32.98M to $49.47M. The forecast indicates a -1.14% fall compared to ACCD last annual SG&A of $41.70M (Nov 23).

Accolade EPS Forecast

Mar 27Nov 26Aug 26May 26Mar 26Nov 25Aug 25May 25Mar 25Nov 24Aug 24May 24Mar 24Nov 23Aug 23May 23Mar 23Dec 22Aug 22May 22Mar 22Dec 21Aug 21May 21Mar 21Dec 20Aug 20May 20
# Analysts554843369949910998154475558555
EPS-------------$-0.00$-0.43$-0.52--$-0.66$-4.92--$-0.97$-0.84--$-0.47$-0.30
Avg Forecast$0.13$-0.20$-0.24$-0.28$0.10$-0.26$-0.29$-0.32$0.05$-0.32$-0.44$-0.48$-0.11$-0.45$-0.54$-0.62$-0.41$1.95$-0.72$-0.74$-0.42$-0.78$-0.59$-0.35$-0.09$-0.33$-0.40$-0.37
High Forecast$0.14$-0.19$-0.23$-0.27$0.11$-0.25$-0.27$-0.30$0.10$-0.27$-0.42$-0.46$-0.11$-0.36$-0.51$-0.59$-0.40$2.01$-0.70$-0.72$-0.41$-0.75$-0.57$-0.34$-0.09$-0.32$-0.39$-0.36
Low Forecast$0.13$-0.21$-0.25$-0.29$0.10$-0.27$-0.29$-0.32$-0.03$-0.37$-0.45$-0.49$-0.12$-0.51$-0.55$-0.63$-0.43$1.86$-0.74$-0.76$-0.43$-0.80$-0.60$-0.36$-0.09$-0.34$-0.41$-0.38
Surprise %-------------0.00%0.80%0.84%--0.92%6.67%--1.65%2.39%--1.17%0.81%

According to undefined Wall Street analysts, Accolade's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ACCD previous annual EPS of $NaN (undefined).

Accolade Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
EVHEvolent Health$10.41$22.50116.14%Buy
HCATHealth Catalyst$5.63$9.0059.86%Buy
DHDefinitive Healthcare$4.93$6.0823.33%Hold
PHRPhreesia$28.71$30.757.11%Buy
PRVAPrivia Health Group$22.51$23.675.15%Buy
CERTCertara$13.89$14.504.39%Buy
ACCDAccolade$6.88$7.032.18%Hold
HSTMHealthStream$32.38$29.00-10.44%Buy
PINCPremier$22.80$20.00-12.28%Hold

ACCD Forecast FAQ

Is Accolade a good buy?

No, according to 17 Wall Street analysts, Accolade (ACCD) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 47.06% of ACCD's total ratings.

What is ACCD's price target?

Accolade (ACCD) average price target is $7.03 with a range of $7.03 to $7.03, implying a 2.18% from its last price of $6.88. The data is based on 17 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Accolade stock go up soon?

According to Wall Street analysts' prediction for ACCD stock, the company can go up by 2.18% (from the last price of $6.88 to the average price target of $7.03), up by 2.18% based on the highest stock price target, and up by 2.18% based on the lowest stock price target.

Can Accolade stock reach $10?

ACCD's average twelve months analyst stock price target of $7.03 does not support the claim that Accolade can reach $10 in the near future.

What is Accolade's current price target trend?

2 Wall Street analysts forecast a $7.03 price target for Accolade (ACCD) this month, up 2.18% from its last price of $6.88. Compared to the last 3 and 12 months, the average price target increased by 2.18% and increased by 17.15%, respectively.

Did the ACCD's actual financial results beat the analysts' financial forecasts?

In terms of the last quarterly report (Nov 2023), Accolade's revenue was $99.37M, beating the average analysts' forecast of $96.16M by 3.34%. The company's EBITDA was $-8.29M, missing the average prediction of $-27.417M by -69.76%. Accolade's net income was $-21.064M, missing the average estimation of $-36.06M by -41.59%. The company's SG&A was $41.7M, missing the average forecast of $44.14M by -5.52%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $-0.447 by -99.93%